P. C. Petersen, L. N. Petersen, I. Vogelius, J. K. Bjerregaard, and L. Baeksgaard, “A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma”, AO, vol. 60, no. 7, pp. 948–953, Jul. 2021.